CervoMed Inc. Files 8-K on Shareholder Votes & Financials
Ticker: CRVO · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1053691
| Field | Detail |
|---|---|
| Company | Cervomed Inc. (CRVO) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financials, filing
TL;DR
CervoMed filed an 8-K covering shareholder votes and financials. Check it for updates.
AI Summary
CervoMed Inc. filed an 8-K on June 25, 2025, reporting on matters submitted to a vote of security holders and financial statements. The company, formerly known as Diffusion Pharmaceuticals Inc., RestorGenex Corp, and Stratus Media Group, Inc., is incorporated in Delaware and headquartered in Boston, MA.
Why It Matters
This filing provides updates on corporate governance and financial health, which are crucial for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing reporting on standard corporate actions and financial statements, not indicating any immediate operational or financial distress.
Key Players & Entities
- CervoMed Inc. (company) — Registrant
- Diffusion Pharmaceuticals Inc. (company) — Former Company Name
- RestorGenex Corp (company) — Former Company Name
- Stratus Media Group, Inc (company) — Former Company Name
- 20250623 (date) — Date of earliest event reported
- 20250625 (date) — Filing Date
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that 'Submission of Matters to a Vote of Security Holders' is an item reported, but the specific details of these matters are not provided in the excerpt.
What is the primary business of CervoMed Inc.?
CervoMed Inc. is in the 'PHARMACEUTICAL PREPARATIONS' industry, with SIC code 2834.
When did CervoMed Inc. change its name from Diffusion Pharmaceuticals Inc.?
The date of the name change from Diffusion Pharmaceuticals Inc. was January 15, 2016.
Where is CervoMed Inc.'s principal executive office located?
CervoMed Inc.'s principal executive offices are located at 20 Park Plaza, Suite 424, Boston, Massachusetts 02116.
What is the Commission File Number for CervoMed Inc.?
The Commission File Number for CervoMed Inc. is 001-37942.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding CervoMed Inc. (CRVO).